Csaky, K., & Do, D. V. (2009). Safety Implications of Vascular Endothelial Growth Factor Blockade for Subjects Receiving Intravitreal Anti–Vascular Endothelial Growth Factor Therapies. American journal of ophthalmology, 148(5), 647-656. https://doi.org/10.1016/j.ajo.2009.06.014
Chicago Style (17th ed.) CitationCsaky, Karl, and Diana V. Do. "Safety Implications of Vascular Endothelial Growth Factor Blockade for Subjects Receiving Intravitreal Anti–Vascular Endothelial Growth Factor Therapies." American Journal of Ophthalmology 148, no. 5 (2009): 647-656. https://doi.org/10.1016/j.ajo.2009.06.014.
MLA (9th ed.) CitationCsaky, Karl, and Diana V. Do. "Safety Implications of Vascular Endothelial Growth Factor Blockade for Subjects Receiving Intravitreal Anti–Vascular Endothelial Growth Factor Therapies." American Journal of Ophthalmology, vol. 148, no. 5, 2009, pp. 647-656, https://doi.org/10.1016/j.ajo.2009.06.014.